BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 5713587)

  • 1. [Protection of muscle cholinestarase from irreversible inactivation with armin by means of some miorelaxants].
    Shumova IA
    Farmakol Toksikol; 1968; 31(6):721-5. PubMed ID: 5713587
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inhibition of cholinesterase in the myoneural synapses by decamethonium and ditilin].
    Danilov AF
    Farmakol Toksikol; 1967; 30(6):664-9. PubMed ID: 5598433
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of cholinesterase in the neuromuscular effects of succinylcholine, decamethonium and hexafluorenium.
    Scaf AH; van den Akker J; Westenberg HG
    Arch Int Pharmacodyn Ther; 1974 Mar; 208(1):177-92. PubMed ID: 4846189
    [No Abstract]   [Full Text] [Related]  

  • 4. [The mechanism of blockade and recovery of neuromuscular transmission under the influence of armin in experiments on cats].
    Danilov AF; Ivanov IuIa
    Farmakol Toksikol; 1972; 35(5):571-5. PubMed ID: 4346937
    [No Abstract]   [Full Text] [Related]  

  • 5. [Myoneural conduction blockade by choline esters in the presence of cholinesterase inhibitors and restoration of conduction by cholinesterase reactivators].
    Protas LL
    Dokl Akad Nauk SSSR; 1973 Apr; 209(5):1243-6. PubMed ID: 4350639
    [No Abstract]   [Full Text] [Related]  

  • 6. [Inhibition of cat skeletal muscle cholinesterases by depolarizing myorelaxants].
    Danilov AF; Malygin VV
    Dokl Akad Nauk SSSR; 1976 Jan; 226(1):227-9. PubMed ID: 1248356
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effect of tetanization of a skeletal muscle motor nerve on the blocking and anticholinesterase effect of armin and compound GD-42].
    Ivanov IuIa; Danilov AF; Zelikson BB; Mikhel'son MIa
    Farmakol Toksikol; 1972; 35(5):567-70. PubMed ID: 4652006
    [No Abstract]   [Full Text] [Related]  

  • 8. [Role of substrate inhibition of myoneural junction acetylcholinesterase in the mechanism of the blocking action of irreversible cholinesterase inhibitors on neuromuscular behavior].
    Ivanov IuIa
    Dokl Akad Nauk SSSR; 1972 Feb; 202(6):1464-6. PubMed ID: 5012275
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of so-called "depolarizing" and "repolarizing" substances on neuromuscular excitability].
    Quevauviller A; Levy JC
    Anesth Analg (Paris); 1967; 24(2):247-68. PubMed ID: 4383825
    [No Abstract]   [Full Text] [Related]  

  • 10. [Presynaptic action of the organophosphorus cholinesterase inhibitor armin on the neuromuscular synapse of the frog sartorius muscle].
    Skliarov AI
    Dokl Akad Nauk SSSR; 1975 Nov; 225(2):454-6. PubMed ID: 1204478
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of an organic phosphate on the response of denervated muscle to acetylcholine and some neuromuscular blocking agents.
    Loomis TA; Konker AC
    Arch Int Pharmacodyn Ther; 1967 Feb; 165(2):308-18. PubMed ID: 6031465
    [No Abstract]   [Full Text] [Related]  

  • 12. The interaction of hexafluorenium with other neuromuscular blocking agents in man.
    Foldes FF
    Anaesthesist; 1966 Mar; 15(3):75-8. PubMed ID: 4383609
    [No Abstract]   [Full Text] [Related]  

  • 13. [Influence of the selective inhibition of true cholinesterase and false cholinesterase on muscular development in the chick embryo].
    Manin D; Zatti P
    Boll Soc Ital Biol Sper; 1968 Oct; 44(19):1586-8. PubMed ID: 5712365
    [No Abstract]   [Full Text] [Related]  

  • 14. [Kinetics of armin and phosphacol interaction with cholinesterases of different organs and tissues].
    Markov SM; Loshadkin NA; Imasheva MA
    Farmakol Toksikol; 1966; 29(1):72-6. PubMed ID: 5988621
    [No Abstract]   [Full Text] [Related]  

  • 15. The interactions of neuromuscular blocking agents in man: the role of hexafluorenium.
    Torda TA; Foldes FF; Bailey RJ; Klonymus DH; Kuwabara S
    Anesthesiology; 1967; 28(6):1010-9. PubMed ID: 4383425
    [No Abstract]   [Full Text] [Related]  

  • 16. [Current views on the mechanism of action of neuromuscular blocking agents].
    Foldes FF
    Acta Anaesthesiol Scand Suppl; 1966; 25():207-18. PubMed ID: 6003288
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study of the effectiveness of cholinolytics as antidotes in poisoning with anticholinesterase compounds of mice and rats].
    Prozorovskiĭ VB
    Farmakol Toksikol; 1968; 31(5):553-6. PubMed ID: 4387719
    [No Abstract]   [Full Text] [Related]  

  • 18. Decrease in cholinesterase activity of single motor end-plates after thiocholine staining.
    Buckley GA; Heaton J
    Br J Pharmacol; 1969 Feb; 35(2):P370-1. PubMed ID: 4180115
    [No Abstract]   [Full Text] [Related]  

  • 19. [To the mechanism of the disorder of higher nervous activity caused by anticholinesterase compounds].
    Golikov SN; Razumova MA; Selivanova AT
    Farmakol Toksikol; 1968; 31(2):145-9. PubMed ID: 5674663
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the penetration of proserine through the hemato-encephalic barrier].
    Shumova IA
    Farmakol Toksikol; 1967; 30(6):669-74. PubMed ID: 4386298
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.